Xilio Therapeutics Statistics

Total Valuation

XLO has a market cap or net worth of $42.45 million. The enterprise value is $14.65 million.

Market Cap	42.45M
Enterprise Value	14.65M

Important Dates

The last earnings date was Tuesday, May 14, 2024, before market open.

Earnings Date	May 14, 2024
Ex-Dividend Date	n/a

Share Statistics

XLO has 36.91 million shares outstanding. The number of shares has increased by 1.75% in one year.

Shares Outstanding	36.91M
Shares Change (YoY)	+1.75%
Shares Change (QoQ)	+1.29%
Owned by Insiders (%)	25.79%
Owned by Institutions (%)	37.01%
Float	20.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.65
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.19, with a Debt / Equity ratio of 0.35.

Current Ratio	2.19
Quick Ratio	2.11
Debt / Equity	0.35
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -155.60% and return on invested capital (ROIC) is -210.59%.

Return on Equity (ROE)	-155.60%
Return on Assets (ROA)	-90.50%
Return on Capital (ROIC)	-210.59%
Revenue Per Employee	n/a
Profits Per Employee	-$972,068
Employee Count	73
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -63.58% in the last 52 weeks. The beta is -0.09, so XLO's price volatility has been lower than the market average.

Beta (1Y)	-0.09
52-Week Price Change	-63.58%
50-Day Moving Average	1.06
200-Day Moving Average	1.40
Relative Strength Index (RSI)	51.07
Average Volume (30 Days)	1,244,553

Short Selling Information

The latest short interest is 456,506, so 1.24% of the outstanding shares have been sold short.

Short Interest	456,506
Short Previous Month	379,490
Short % of Shares Out	1.24%
Short % of Float	2.26%
Short Ratio (days to cover)	0.29

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-73.09M
Pretax Income	-70.96M
Net Income	-70.96M
EBITDA	-69.12M
EBIT	-70.96M
Earnings Per Share (EPS)	-$2.57

Full Income Statement

Balance Sheet

The company has $36.74 million in cash and $8.94 million in debt, giving a net cash position of $27.80 million or $0.75 per share.

Cash & Cash Equivalents	36.74M
Total Debt	8.94M
Net Cash	27.80M
Net Cash Per Share	$0.75
Equity / Book Value	25.77M
Book Value Per Share	0.70
Working Capital	37.60M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$53.87 million and capital expenditures -$316,000, giving a free cash flow of -$54.19 million.

Operating Cash Flow	-53.87M
Capital Expenditures	-316,000
Free Cash Flow	-54.19M
FCF Per Share	-$1.94

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

XLO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.75%
Shareholder Yield	-1.75%
Earnings Yield	-167.15%
FCF Yield	-127.64%

Analyst Forecast

The average price target for XLO is $7.00, which is 514.04% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.00
Price Target Difference	514.04%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-27.02%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2